E. Minatel et al., COMBINED RADIOTHERAPY AND BLEOMYCIN IN PATIENTS WITH INOPERABLE HEAD AND NECK-CANCER WITH UNFAVORABLE PROGNOSTIC FACTORS AND SEVERE SYMPTOMS, Oral Oncology, 34(2), 1998, pp. 119-122
The aim of this study was to assess the feasibility of concurrent spli
t course radiotherapy and low-dose bleomycin in the treatment of unres
ectable head and neck cancer with unfavourable prognostic factors and
severe syptoms. The clinical outcome of the treatment was assessed in
terms of local disease control, symptom relief and toxicity. Between 1
990 and 1996, 58 patients with squamous cell carcinoma of the head and
neck, stage III or IV, were treated by radiotherapy (50 Gy/20 fractio
ns) and simultaneous bleomycin (60 mg/6 fractions). Local control of d
isease, overall response, symptom relief and acute toxicity were evalu
ated. The rate of disease local control was 69% with a median response
duration of 7 months (range 2-43 +). The symptom relief rate was 81%.
Mucositis was the prominent toxicity: G3 mucositis was reported in 27
patients. In conclusion, the treatment was feasible, a good palliatio
n of symptoms and a good rate of local response were obtained. Moreove
r, toxicity was tolerable and the rate of hospitalisation was low. (C)
1998 Elsevier Science Ltd. All rights reserved.